Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,276,424 papers from all fields of science
Search
Sign In
Create Free Account
Progressive Disease
Known as:
Disease Progression
, PD
A disease process that is increasing in scope or severity.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
Clinical Data Interchange Standards Consortium Terminology
Disease Progression
Metastatic Malignant Peripheral Nerve Sheath Tumor
Mycosis Fungoides
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Pembrolizumab plus Chemotherapy in Metastatic Non–Small‐Cell Lung Cancer
L. Gandhi
,
D. Rodríguez-Abreu
,
+26 authors
M. Garassino
New England Journal of Medicine
2018
Corpus ID: 4895220
BACKGROUND First‐line therapy for advanced non–small‐cell lung cancer (NSCLC) that lacks targetable mutations is platinum‐based…
Expand
Review
2016
Review
2016
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
M. Reck
,
D. Rodríguez-Abreu
,
+15 authors
J. Brahmer
New England Journal of Medicine
2016
Corpus ID: 9944410
BACKGROUND Pembrolizumab is a humanized monoclonal antibody against programmed death 1 (PD-1) that has antitumor activity in…
Expand
Review
2014
Review
2014
Remodelling the extracellular matrix in development and disease
C. Bonnans
,
J. Chou
,
Z. Werb
Nature reviews. Molecular cell biology
2014
Corpus ID: 12711748
The extracellular matrix (ECM) is a highly dynamic structure that is present in all tissues and continuously undergoes controlled…
Expand
Review
2007
Review
2007
Microglia: active sensor and versatile effector cells in the normal and pathologic brain
U. Hanisch
,
H. Kettenmann
Nature Neuroscience
2007
Corpus ID: 28301217
Microglial cells constitute the resident macrophage population of the CNS. Recent in vivo studies have shown that microglia carry…
Expand
Highly Cited
2004
Highly Cited
2004
Circulating tumor cells, disease progression, and survival in metastatic breast cancer.
M. Cristofanilli
,
G. Budd
,
+8 authors
D. Hayes
New England Journal of Medicine
2004
Corpus ID: 7445998
BACKGROUND We tested the hypothesis that the level of circulating tumor cells can predict survival in metastatic breast cancer…
Expand
Highly Cited
2003
Highly Cited
2003
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.
J. Hill
,
G. Zalos
,
+4 authors
T. Finkel
New England Journal of Medicine
2003
Corpus ID: 29844251
BACKGROUND Cardiovascular risk factors contribute to atherogenesis by inducing endothelial-cell injury and dysfunction. We…
Expand
Highly Cited
2003
Highly Cited
2003
Coronavirus as a possible cause of severe acute respiratory syndrome
J. Peiris
,
S. Lai
,
+13 authors
K. Yuen
The Lancet
2003
Corpus ID: 767662
Highly Cited
2000
Highly Cited
2000
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.
A. Gramont
,
A. Figer
,
+15 authors
A. Bonetti
Journal of Clinical Oncology
2000
Corpus ID: 45209302
PURPOSE In a previous study of treatment for advanced colorectal cancer, the LV5FU2 regimen, comprising leucovorin (LV) plus…
Expand
Review
1999
Review
1999
Natural history of progression after PSA elevation following radical prostatectomy.
C. Pound
,
A. Partin
,
M. Eisenberger
,
Daniel W. Chan
,
J. Pearson
,
P. Walsh
Journal of the American Medical Association (JAMA…
1999
Corpus ID: 6651262
CONTEXT In men who develop an elevated serum prostate-specific antigen level (PSA) after having undergone a radical prostatectomy…
Expand
Highly Cited
1996
Highly Cited
1996
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene
M. Dean
,
M. Carrington
,
+14 authors
S. O’Brien
Science
1996
Corpus ID: 21160580
The chemokine receptor 5 (CKR5) protein serves as a secondary receptor on CD4+ T lymphocytes for certain strains of human…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE